Biotinylated Monoclonal Valproic Acid Antibody
<strong>Biotinylated Monoclonal Valproic Acid Antibody</strong>_x000D_ <strong>Catalog number:</strong> B2019293_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 100 ug_x000D_ <strong>Molecular Weight or Concentration:</strong> NA_x000D_ <strong>Supplied as:</strong> Solution_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -20°C_x000D_ <strong>Keywords:</strong> Biotin Monoclonal Valproic Acid Antibody_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Lampl C, MaassenVanDenBrink A, Deligianni CI, Gil-Gouveia R, Jassal T, Sanchez-Del-Rio M, Reuter U, Uluduz D, Versijpt J, Zeraatkar D, Sacco S. The comparative effectiveness of migraine preventive drugs: a systematic review and network meta-analysis J Headache Pain. 2023 May 19;24(1):56._x000D_ 2: Bateman RM, Sharpe MD, Jagger JE, Ellis CG, Solé-Violán J, López-Rodríguez M, Herrera-Ramos E, Ruíz-Hernández J, Borderías L, Horcajada J, González-Quevedo N, Rajas O, Briones M, Rodríguez de Castro F, Rodríguez Gallego C, Esen F, Orhun G, Ergin Ozcan P, Senturk E, Ugur Yilmaz C, Orhan N, Arican N, Kaya M, Kucukerden M, Giris M, Akcan U, Bilgic Gazioglu S, Tuzun E, Riff R, Naamani O, Douvdevani A, Takegawa R, Yoshida H, Hirose T, Yamamoto N, Hagiya H, Ojima M, Akeda Y, Tasaki O, Tomono K, Shimazu T, Ono S, Kubo T, Suda S, Ueno T, Ikeda T, Hirose T, Ogura H, Takahashi H, Ojima M, Kang J, Nakamura Y, Kojima T, Shimazu T, Ikeda T, Suda S, Izutani Y, Ueno T, Ono S, Taniguchi T, O M, Dinter C, Lotz J, Eilers B, Wissmann C, Lott R, Meili MM, Schuetz PS, Hawa H, Sharshir M, Aburageila M, Salahuddin N, Chantziara V, Georgiou S, Tsimogianni A, Alexandropoulos P, Vassi A, Lagiou F, Valta M, Micha G, Chinou E, Michaloudis G, Kodaira A, Ikeda T, Ono S, Ueno T, Suda S, Izutani Y, Imaizumi H, De la Torre-Prados MV, Garcia-De la Torre A, Enguix-Armada A, Puerto-Morlan A, Perez-Valero V, Garcia-Alcantara A, Bolton N, Dudziak J, Bonney S, Tridente A, Nee P, et al. 36th International Symposium on Intensive Care and Emergency Medicine : Brussels, Belgium. 15-18 March 2016 Crit Care. 2016 Apr 20;20(Suppl 2):94._x000D_ 3: Kikui S, Takeshima T. [Migraine Medication] Brain Nerve. 2023 May;75(5):470-478._x000D_ 4: Laengle J, Kabiljo J, Hunter L, Homola J, Prodinger S, Egger G, Bergmann M. Histone deacetylase inhibitors valproic acid and vorinostat enhance trastuzumab-mediated antibody-dependent cell-mediated phagocytosis J Immunother Cancer. 2020 Jan;8(1):e000195._x000D_ 5: Wheler JJ, Janku F, Falchook GS, Jackson TL, Fu S, Naing A, Tsimberidou AM, Moulder SL, Hong DS, Yang H, Piha-Paul SA, Atkins JT, Garcia-Manero G, Kurzrock R. Phase I study of anti-VEGF monoclonal antibody bevacizumab and histone deacetylase inhibitor valproic acid in patients with advanced cancers Cancer Chemother Pharmacol. 2014 Mar;73(3):495-501._x000D_ 6: Yang WC, Lu J, Nguyen NB, Zhang A, Healy NV, Kshirsagar R, Ryll T, Huang YM. Addition of valproic acid to CHO cell fed-batch cultures improves monoclonal antibody titers Mol Biotechnol. 2014 May;56(5):421-8._x000D_ 7: Thangwaritorn S, Lee C, Metchikoff E, Razdan V, Ghafary S, Rivera D, Pinto A, Pemminati S. A Review of Recent Advances in the Management of Alzheimer's Disease Cureus. 2024 Apr 16;16(4):e58416._x000D_ 8: Leone M, Giustiniani A, Cecchini AP. Cluster headache: present and future therapy Neurol Sci. 2017 May;38(Suppl 1):45-50._x000D_ 9: Diener HC, Rizzoli P. Chronic migraine and medication overuse Handb Clin Neurol. 2023;198:187-200._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/38157876">10: Kowacs PA, Sampaio Rocha-Filho PA, Peres MFP, Edvinsson L. The history and rationale of the development of new drugs for migraine treatment Arq Neuropsiquiatr. 2023 Dec;81(12):1084-1097. </a>_x000D_ _x000D_ <strong>Products Related to Biotinylated Monoclonal Valproic Acid Antibody can be found at</strong> <a href="https://moleculardepot.com/product-category/Conjugates/"> Conjugates</a>
Product Specifications
Short Description
Catalog Number: B2019293 (100 ug)
Weight
0.15
Length
2
Width
0.5
Height
0.5
CAS Number
9007-83-4
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items